BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen X, Ma H, Gao Y, Jin Y, Ning W, Hou Y, Su J. Long non-coding RNA AC012668 suppresses non-alcoholic fatty liver disease by competing for microRNA miR-380-5p with lipoprotein-related protein LRP2. Bioengineered 2021;12:6738-47. [PMID: 34511037 DOI: 10.1080/21655979.2021.1960463] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Tang J, Chuang Y, Shiau J, Yang K, Chang F, Hou M, Farooqi AA, Chang H. Long Noncoding RNAs and Circular RNAs Regulate AKT and Its Effectors to Control Cell Functions of Cancer Cells. Cells 2022;11:2940. [DOI: 10.3390/cells11192940] [Reference Citation Analysis]
2 Kazeminasab F, Baharlooie M, Ghaedi K, Mandard S. Noncoding RNAs Associated with PPARs in Etiology of MAFLD as a Novel Approach for Therapeutics Targets. PPAR Research 2022;2022:1-13. [DOI: 10.1155/2022/6161694] [Reference Citation Analysis]
3 Wang Y, Zhao H, Yang L, Zhang H, Yu X, Fei W, Zhen Y, Gao Z, Chen S, Ren L. Quantitative proteomics analysis based on tandem mass tag labeling coupled with labeling coupled with liquid chromatography-tandem mass spectrometry discovers the effect of silibinin on non-alcoholic fatty liver disease in mice. Bioengineered 2022;13:6750-66. [PMID: 35246007 DOI: 10.1080/21655979.2022.2045837] [Reference Citation Analysis]
4 Zou L, Shi C, Wang D, Cheng J, Wang Q, Wang L, Yang G. Long non-coding RNA-non-coding RNA activated by DNA damage inhibition suppresses hepatic stellate cell activation via microRNA-495-3p/sphingosine 1-phosphate receptor 3 axis. Bioengineered 2022;13:6150-62. [PMID: 35200103 DOI: 10.1080/21655979.2022.2037841] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]